Roberto Lorusso1, Michael Mazzeffi2,3, Mirko Belliato1,4,5, Michele Di Mauro1,6, Fabio Silvio Taccone7, Orlando Parise1, Ayat Albanawi1, Veena Nandwani2, Paul McCarthy2, Zachary Kon6, Jay Menaker2, Daniel M Johnson1, Sandro Gelsomino1, Daniel Herr3. 1. Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands. 2. Departments of Anesthesiology, University of Maryland School of Medicine, Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, USA. 3. Departments of Surgery, University of Maryland School of Medicine, Program in Trauma, R Adams Cowley Shock Trauma Center, Baltimore, USA. 4. Cardiac Surgery Unit, University of Chieti, Chieti, Italy. 5. UOC Anestesia e Rianimazione 1, Foundation IRCCS Policlinico San Matteo, Pavia, Italy. 6. Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY, USA. 7. Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles (ULB), Route de Lennik, 808, 1070, Brussels, Belgium. ftaccone@ulb.ac.be.
Abstract
BACKGROUND: Single- (SL) and double-lumen (DL) catheters are used in clinical practice for veno-venous extracorporeal membrane oxygenation (V-V ECMO) therapy. However, information is lacking regarding the effects of the cannulation on neurological complications. METHODS: A retrospective observational study based on data from the Extracorporeal Life Support Organization (ELSO) registry. All adult patients included in the ELSO registry from 2011 to 2018 submitted to a single run of V-V ECMO were analyzed. Propensity score (PS) inverse probability of treatment weighting estimation for multiple treatments was used. The average treatment effect (ATE) was chosen as the causal effect estimate of outcome. The aim of the study was to evaluate differences in the occurrence and the type of neurological complications in adult patients undergoing V-V ECMO when treated with SL or DL cannulas. RESULTS: From a population of 6834 patients, the weighted propensity score matching included 6245 patients (i.e., 91% of the total cohort; 4175 with SL and 20,270 with DL cannulation). The proportion of patients with at least one neurological complication was similar in the SL (306, 7.2%) and DL (189, 7.7%; odds ratio 1.10 [95% confidence intervals 0.91-1.32]; p = 0.33). After weighted propensity score, the ATE for the occurrence of least one neurological complication was 0.005 (95% CI - 0.009 to 0.018; p = 0.50). Also, the occurrence of specific neurological complications, including intracerebral hemorrhage, acute ischemic stroke, seizures or brain death, was similar between groups. Overall mortality was similar between patients with neurological complications in the two groups. CONCLUSIONS: In this large registry, the occurrence of neurological complications was not related to the type of cannulation in patients undergoing V-V ECMO.
BACKGROUND: Single- (SL) and double-lumen (DL) catheters are used in clinical practice for veno-venous extracorporeal membrane oxygenation (V-V ECMO) therapy. However, information is lacking regarding the effects of the cannulation on neurological complications. METHODS: A retrospective observational study based on data from the Extracorporeal Life Support Organization (ELSO) registry. All adult patients included in the ELSO registry from 2011 to 2018 submitted to a single run of V-V ECMO were analyzed. Propensity score (PS) inverse probability of treatment weighting estimation for multiple treatments was used. The average treatment effect (ATE) was chosen as the causal effect estimate of outcome. The aim of the study was to evaluate differences in the occurrence and the type of neurological complications in adult patients undergoing V-V ECMO when treated with SL or DL cannulas. RESULTS: From a population of 6834 patients, the weighted propensity score matching included 6245 patients (i.e., 91% of the total cohort; 4175 with SL and 20,270 with DL cannulation). The proportion of patients with at least one neurological complication was similar in the SL (306, 7.2%) and DL (189, 7.7%; odds ratio 1.10 [95% confidence intervals 0.91-1.32]; p = 0.33). After weighted propensity score, the ATE for the occurrence of least one neurological complication was 0.005 (95% CI - 0.009 to 0.018; p = 0.50). Also, the occurrence of specific neurological complications, including intracerebral hemorrhage, acute ischemic stroke, seizures or brain death, was similar between groups. Overall mortality was similar between patients with neurological complications in the two groups. CONCLUSIONS: In this large registry, the occurrence of neurological complications was not related to the type of cannulation in patients undergoing V-V ECMO.
Authors: Antonio Rubino; Alain Vuylsteke; David P Jenkins; Jo-Anne Fowles; Lisen Hockings; Kamen Valchanov Journal: Int J Artif Organs Date: 2014-10-13 Impact factor: 1.595
Authors: M Marinoni; M L Migliaccio; S Trapani; M Bonizzoli; L Gucci; G Cianchi; A Gallerini; L Tadini Buoninsegni; A Cramaro; S Valente; M Chiostri; A Peris Journal: Acta Anaesthesiol Scand Date: 2016-04-24 Impact factor: 2.105
Authors: Roberto Lorusso; Sandro Gelsomino; Orlando Parise; Michele Di Mauro; Fabio Barili; Gijs Geskes; Enrico Vizzardi; Peter T Rycus; Raf Muellenbach; Thomas Mueller; Antonio Pesenti; Alain Combes; Giles Peek; Bjorn Frenckner; Matteo Di Nardo; Justyna Swol; Jos Maessen; Ravi R Thiagarajan Journal: Crit Care Med Date: 2017-08 Impact factor: 7.598
Authors: Farrah J Mateen; Rajanandini Muralidharan; Russell T Shinohara; Joseph E Parisi; Gregory J Schears; Eelco F M Wijdicks Journal: Arch Neurol Date: 2011-08-08
Authors: Eddy Fan; Luciano Gattinoni; Alain Combes; Matthieu Schmidt; Giles Peek; Dan Brodie; Thomas Muller; Andrea Morelli; V Marco Ranieri; Antonio Pesenti; Laurent Brochard; Carol Hodgson; Cecile Van Kiersbilck; Antoine Roch; Michael Quintel; Laurent Papazian Journal: Intensive Care Med Date: 2016-03-23 Impact factor: 17.440
Authors: David B Tulman; Stanislaw P A Stawicki; Bryan A Whitson; Saarik C Gupta; Ravi S Tripathi; Michael S Firstenberg; Don Hayes; Xuzhong Xu; Thomas J Papadimos Journal: BMC Anesthesiol Date: 2014-08-06 Impact factor: 2.217